RNA-based markers as prognostic factors in chronic lymphocytic leukemia
- 1 February 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Hematology
- Vol. 5 (1) , 69-79
Abstract
Chronic lymphocytic leukemia (CLL) is most often indolent at diagnosis but has a highly variable clinical course, and many patients will eventually progress and require treatment. Currently, there are a number of clinical and molecular markers known to be predictive of prognosis in CLL that can be applied to discriminate patients that are more likely to develop a progressive disease. Gene-expression profiling studies have identified genes with differential expression between prognostic subgroups in CLL, and research on these RNA-based prognostic markers has expanded during recent years. For example, high lipoprotein lipase and CLLU1 mRNA expression have recently been shown to be strong markers of poor clinical outcome. In this review we will provide a summary of the most significant prognostic markers in CLL, focusing on the recent category of RNA-based markers in particular.Keywords
This publication has 113 references indexed in Scilit:
- miR-181b is a biomarker of disease progression in chronic lymphocytic leukemiaBlood, 2011
- High TCL1 levels are a marker of B-cell receptor pathway responsiveness and adverse outcome in chronic lymphocytic leukemiaBlood, 2009
- Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2009
- Small silencing RNAs: an expanding universeNature Reviews Genetics, 2009
- Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabBlood, 2009
- Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLLProceedings of the National Academy of Sciences, 2008
- Genomic complexity identifies patients with aggressive chronic lymphocytic leukemiaBlood, 2008
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelinesBlood, 2008
- Overexpression of the paternally expressed gene 10 (PEG10) from the imprinted locus on chromosome 7q21 in high‐risk B‐cell chronic lymphocytic leukemiaInternational Journal of Cancer, 2007
- B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemiaProceedings of the National Academy of Sciences, 2006